Black Rock Inc. Jaguar Health, Inc. Transaction History

Black Rock Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$0.08 - $809.55 $44 - $449,300	-555 Reduced 0.09%	651,518 $58,000
Q3 2022 Nov 14, 2022	SELL	$0.17 - $765.0 $146 - $658,665	-861 Reduced 0.13%	652,073 $101,000
Q2 2022 Aug 12, 2022	SELL	$0.27 - $0.71 $30,460 - $80,099	-112,816 Reduced 14.73%	652,934 $192,000
Q1 2022 May 12, 2022	SELL	$0.38 - $1.07 $2,014 - $5,672	-5,301 Reduced 0.69%	765,750 $543,000
Q4 2021 Feb 10, 2022	SELL	$1.03 - $2.48 $9,330 - $22,466	-9,059 Reduced 1.16%	771,051 $802,000
Q3 2021 Nov 09, 2021	BUY	$2.14 - $4.95 $1.67 Million - $3.86 Million	780,110 New	780,110 $1.77 Million

Ticker JAGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 119,861,000
Market Cap $127M
Description
Jaguar Health, Inc., a commercial stage pharmaceuticals company, focuses on developing prescription medicines for people and animals with gastrointestinal distress, specifically chronic, and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It markets Mytesi for the symptomatic relief of noninfecti...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.